[go: up one dir, main page]

MX2012004133A - Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas. - Google Patents

Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.

Info

Publication number
MX2012004133A
MX2012004133A MX2012004133A MX2012004133A MX2012004133A MX 2012004133 A MX2012004133 A MX 2012004133A MX 2012004133 A MX2012004133 A MX 2012004133A MX 2012004133 A MX2012004133 A MX 2012004133A MX 2012004133 A MX2012004133 A MX 2012004133A
Authority
MX
Mexico
Prior art keywords
compositions
methods
adjuvant
macrolide
proteinaceous antigen
Prior art date
Application number
MX2012004133A
Other languages
English (en)
Inventor
Nahla Fattohi
Terry Kaleung Ng
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of MX2012004133A publication Critical patent/MX2012004133A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a composiciones que comprenden un adyuvante de aceite, una lactona macrocíclica eficaz para la prevención o combate de una infección parasitaria en un animal de sangre caliente y una cantidad inmunizante de al menos un polipéptido inmunogénico y a procedimientos de uso de las mismas.
MX2012004133A 2009-10-07 2010-09-29 Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas. MX2012004133A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24945409P 2009-10-07 2009-10-07
PCT/US2010/050630 WO2011043962A2 (en) 2009-10-07 2010-09-29 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2012004133A true MX2012004133A (es) 2012-05-08

Family

ID=43707921

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004133A MX2012004133A (es) 2009-10-07 2010-09-29 Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.

Country Status (9)

Country Link
US (1) US20110091559A1 (es)
EP (1) EP2485725A2 (es)
AR (1) AR078539A1 (es)
AU (1) AU2010303741A1 (es)
BR (1) BR112012008185A2 (es)
MX (1) MX2012004133A (es)
TW (1) TW201127398A (es)
UY (1) UY32930A (es)
WO (1) WO2011043962A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272144B2 (en) * 2013-07-31 2019-04-30 Bioventures, Llc Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
DK3116541T3 (da) 2014-03-12 2020-02-24 Bavarian Nordic As Anvendelse af olie-og-vand-emulsioner til forøgelse af b-celleresponser med modificerede vaccinia-ankara-virus
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine
CN110898216B (zh) * 2019-12-31 2021-12-03 中国农业科学院兰州兽医研究所 重组旋毛虫硫氧还蛋白过氧化物酶2在制备抗旋毛虫感染疫苗中的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4389397A (en) 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
US4853372A (en) 1983-12-22 1989-08-01 Merck & Co., Inc. Non-aqueous ivermectin formulation with improved antiparasitic activity
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US5019589A (en) 1986-09-12 1991-05-28 American Cyanamid Company Δ23 -LL-F28249 compounds
US4886828A (en) 1986-09-12 1989-12-12 American Cyanamid Company Δ22 -derivatives of LL-F28249 compounds
GB8813150D0 (en) 1988-06-03 1988-07-06 American Cyanamid Co Chemical compounds
ES2052173T3 (es) * 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5030650A (en) 1989-09-11 1991-07-09 American Cyanamid Company 13-halo-23-imino derivatives of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
US5055486A (en) 1989-12-22 1991-10-08 American Cyanamid Company 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
ATE134873T1 (de) 1991-07-23 1996-03-15 American Cyanamid Co Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung
PT666919E (pt) 1992-10-21 2003-09-30 John Pius Dalton Vacina contendo uma protease de tiol
CA2126455A1 (en) * 1993-02-05 1994-08-06 Andrew R. Milner Liver fluke vaccine and polypeptides useful for same
GB9312324D0 (en) 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
AU7349596A (en) 1995-05-17 1996-12-11 International Centre of Insect Physiology and Ecology, The Novel method of enhancing efficiency of anti-arthropod agents against blood-feeding ectoparasites
ATE214603T1 (de) 1995-06-30 2002-04-15 American Cyanamid Co Stabile makrolide und makrolide imptstoff- zusammensetzungen
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
EP0928136B1 (en) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injectable compositions
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
KR20040028952A (ko) * 2001-07-27 2004-04-03 와이어쓰 웨스트 나일 백신
TWI350174B (en) * 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition

Also Published As

Publication number Publication date
WO2011043962A3 (en) 2011-06-03
US20110091559A1 (en) 2011-04-21
WO2011043962A2 (en) 2011-04-14
BR112012008185A2 (pt) 2016-08-16
UY32930A (es) 2011-05-31
TW201127398A (en) 2011-08-16
AR078539A1 (es) 2011-11-16
AU2010303741A1 (en) 2012-04-19
EP2485725A2 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
MX2009003325A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua.
EA201001479A1 (ru) Вакцина
MX375202B (es) Composiciones adyuvantes novedosas.
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
PH12015500092A1 (en) Compositions for immunising against staphylococcus aureus
NZ700477A (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX352478B (es) Proteina vp6 de la capside de norovirus y rotavirus para el uso como vacuna combinada.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
WO2010132561A8 (en) New human rotavirus strains and vaccines
WO2009135199A3 (en) Vaccine compositions and methods
MX2012004133A (es) Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
WO2011007359A3 (en) Antigen specific multi epitope -based anti-infective vaccines
WO2008043000A3 (en) Ehrlicia canis diva (differentiate infected from vaccinated animals)
IN2014CN03454A (es)
EA201001478A1 (ru) Вакцина
WO2008057158A3 (en) Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
EA201290319A1 (ru) Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания
WO2009037262A3 (en) Method of preventing early lawsonia intracellularis infections
WO2007120860A3 (en) Nanoemulsion vaccines
WO2008044149A8 (en) Shigella ipad protein and its use as a vaccine against shigella infection
SG147465A1 (en) Vaccine
MY158116A (en) Combination vaccine against streptococcus
WO2012075104A3 (en) Novel non-primate hepacivirus
WO2011011725A3 (en) Use of toxoplasma and derived compositions to prevent or treat microbial infections
WO2009129498A3 (en) Substance p and analogs thereof as a cancer immunogenic composition adjuvant

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ZOETIS W LLC

HC Change of company name or juridical status

Owner name: ZOETIS W LLC

FA Abandonment or withdrawal